Bioorganic and Medicinal Chemistry p. 2045 - 2055 (2013)
Update date:2022-08-02
Topics:
Kusakabe, Ken-Ichi
Tada, Yukio
Iso, Yasuyoshi
Sakagami, Masahiro
Morioka, Yasuhide
Chomei, Nobuo
Shinonome, Satomi
Kawamoto, Keiko
Takenaka, Hideyuki
Yasui, Kiyoshi
Hamana, Hiroshi
Hanasaki, Kohji
Selective CB2 agonists have the potential for treating pain without central CB1-mediated adverse effects. Screening efforts identified 1,2-dihydro-3- isoquinolone 1; however, this compound has the drawbacks of being difficult to synthesize with two asymme
View Morewebsite:http://www.amadischem.com
Contact:86-571-89925085
Address:Watts Cosine.No.166.Xiangmao Road.
Tai zhou world Pharm & Chem Co., Ltd
Contact:+86-576-85301198
Address:Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
website:http://www.sigmaaldrich.com
Contact:800 558-9160
Address:Industriestrasse 25CH-9471 Buchs SGSwitzerland
Contact:86-513-84128750/13773795976
Address:No.48.Youyi West Road ,Rudong Development Zone,Jiangsu Province,China
NanJing Rate Biochemicals CO., LTD
Contact:+86-25-84931986
Address:NO. 1 Hongjing Road,Jiangning Science Park,Nanjing,China
Doi:10.1016/S0040-4039(00)84590-6
(1986)Doi:10.1002/hlca.19980810543
(1998)Doi:10.1007/BF00909912
(1970)Doi:10.1039/b001988g
(2000)Doi:10.1021/ja00710a050
(1970)Doi:10.1016/S0040-4039(01)90444-7
(1981)